SEC Form 4 · accession 0000899243-17-008160
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin G. Peters
Officer — Chief Scientific Officer
Period of report
Mar 15, 2017
Accepted (ET)
Mar 17, 2017 · 8:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2017 | P | 3,642 | $5.00 | A | 320,536 | D |
Table II — derivative securities
No Table II lines on this filing.